Valion Bio, Inc. (VBIO)
Nasdaq: VBIO · Electromedical & Electrotherapeutic Apparatus · San Antonio, TX · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Mar 30, 2026 | Mar 21, 2025 | Mar 25, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Revenue | · | 780 | 1,176 | 1,840 | 1,257 |
| For lenders | |||||
| Net interest income | · | 6 | 1 | 2 | -1,823 |
| Cost of revenue | · | 778 | 889 | 1,541 | 1,295 |
| Gross profit | · | 2 | 287 | 299 | -38 |
| Research and development | 3,131 | 1,313 | 1,655 | 1,730 | 878 |
| Selling, general and administrative | 4,767 | 3,163 | · | · | · |
| Sales and marketing | · | 1,187 | 2,125 | 2,792 | 1,787 |
| General and administrative | · | 3,163 | 4,752 | 5,875 | 2,930 |
| Total operating expenses | 7,898 | 4,476r | 8,532 | 10,397 | 5,595 |
| Operating income | -7,898 | -4,476r | -8,245 | -10,098 | -5,633 |
| Interest expense | 146 | 0 | · | · | · |
| Interest and investment income | 23 | 6 | · | · | · |
| Total non-operating income (expense) | -95 | 6 | 1 | 2 | -2,861 |
| Income before income taxes | · | · | -8,244 | -10,096 | · |
| Income tax expense | 0 | 0 | · | · | · |
| Income from continuing operations | -7,993 | -4,470 | · | · | · |
| Income from discontinued operations | -885 | -1,185 | · | · | · |
| Net income including non-controlling interests | · | -5,655 | -8,244 | -10,096 | -8,494 |
| Net income | -8,878 | -5,655 | -8,244 | -10,096 | -8,494 |
| Earnings per share, basic | -7.84 | -19.68 | -176.80r | -1,773.44rb | -4,131.00b |
| Earnings per share, diluted | · | -19.68 | -176.80r | -1,773.44rb | -4,131.00b |
| Weighted average shares, basic | 1,155,531 | 287,370 | 46,650r | 5,693rb | 2,055b |
| Weighted average shares, diluted | · | 287,370 | 46,650r | 5,693rb | 2,055b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-17 reverse split of Mar 2025.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestIncome from discontinued operations profit or loss from businesses it sold or closed
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding